Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Literature
1.
Adams RD, Victor M, Ropper AH (1997) Infections of the central nervous system. Principles of neurology. McGraw Hill, New York
2.
Hoitsma E, Faber CG, Drent M et al (2004) Neurosarcoidosis: a clinical dilemma. Lancet 3:397–405CrossRef
3.
Nowak DA, Widenka DC (2001) Neurosarcoidosis: a review of its intracranial manifestation. J Neurol 248:363–372PubMedCrossRef
4.
5.
6.
Santos E et al (2010) Treatment of refractory neurosarcoidosis with Infliximab. J Neurol Neurosurg Psychiatr 81:241–246PubMedCrossRef
7.
Moravan M, Segal BM (2009) Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 72:337–340PubMedCrossRef
8.
Tong D, Manolios N et al (2012) New-onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognized complication. Intern Med J 42(1):89–94PubMedCrossRef
9.
Daien CI, Monnier A, Claudepierre P et al (2009) Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology 48(8):883–886PubMedCrossRef
10.
Massara A, Cavazzini L, La Corte R, Trotta F (2010) Sarcoidosis appearing during anti-tumor necrosis factor alpha: a new “class effect” Paradoxical Phenomenon. Semin Arthritis Rheum 39:313–319PubMedCrossRef
11.
Sturfelt G, Christensson B et al (2007) Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab. J Rheumatol 34:2313–2314PubMed
12.
Ramos-Casal M, Roberto-Perez-Alvarez, Diaz-Lagares C, Cuadrado M-J, Khamashta MA, and BIOGEAS Study Group (2010) Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 9:188.193
13.
Solomon AJ, Spain RI, Kruer MC, Bourdette D (2011) Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Mult Scler 17(12):1472–1487PubMedCrossRef
Metadata
Title
Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitors
Authors
Yang Mao-Draayer
Tiyonnoh Cash
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 2/2013
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6726-9

Other articles of this Issue 2/2013

Journal of Neurology 2/2013 Go to the issue

Letter to the Editors

Fourth nerve palsy presenting with trochleodynia

Original Communication

Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study

Original Communication

Treatment deviating from guidelines does not influence status epilepticus prognosis

Original Communication

Logopenic syndrome in posterior cortical atrophy

Letter to the Editors

Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica

Pioneers in Neurology

Antonio Scarpa (1752–1832)